Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Application of Precision Partial Intersphincteric Resection (PPISR)

Application of Precision Partial Intersphincteric Resection (PPISR) in Patients With Ultra-low Rectal Cancer

The goal of this study is to establish a standardized operating procedure for Precision Partial Intersphincteric Resection (PPISR), and to evaluate its surgical safety, functional benefits, and oncological efficacy.

Studieöversikt

Studietyp

Interventionell

Inskrivning (Beräknad)

100

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • Zhejiang
      • Wenzhou, Zhejiang, Kina, 325000
        • Rekrytering
        • First Affiliated Hospital of Wenzhou Medical University
        • Kontakt:
          • chunwu zhang
          • Telefonnummer: 86+0577-55578055

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 75 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Patients aged 18-75 years old
  • Pathology suggestive of moderately to highly differentiated rectal adenocarcinoma
  • Tumor lower margin ≤ 5 cm from the anal verge
  • Pre-operative tumor (T) staging of T1-T3 and T1-T2 below the level of the anal raphe muscle
  • No distant metastasis such as lung, liver and other organs

Exclusion Criteria:

  • Preoperative patients with severe underlying diseases (such as severe liver and kidney function, cardiopulmonary function, coagulation dysfunction, etc.)
  • Patients with malignant tumors in other parts of the body
  • Patients who underwent emergency surgery due to acute perforation, obstruction, etc.
  • Patients with tumor infiltration of peripheral organs during the operation, which required combined resection or palliative resection
  • Patients who had a mid-opening laparoscopic operation for various reasons -during the operation
  • Patients with poor anal function before operation, which is not suitable for anus preservation surgery.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: PPISR

The experimental group underwent the PPISR procedure.

The experimental group underwent the PPISR procedure. The surgical process was as follows:

  1. The abdominal team performed the TME procedure, completely resecting the mesorectum at the level of the mesorectum termination line within the levator hiatus.
  2. The transanal team completed routine preoperative preparation and disinfection, and located the distal and lateral resection margins of the tumor (with a margin distance ≥5 mm from the tumor boundary), thereby preserving part of the internal anal sphincter and normal intestinal wall tissue.
  3. A "U"-shaped dissection was performed cranially along the marking line within the intersphincteric space, meeting the abdominal team at the level of the levator hiatus, as shown in Figure 1.
  4. The specimen was removed either transanally or transabdominally.
  5. The proximal intestinal segment was trimmed, intestinal anastomosis was performed manually, and the procedure was concluded.
Aktiv komparator: Traditional ISR

The control group underwent the traditional ISR procedure

The control group underwent the traditional ISR procedure. The surgical process was as follows:

  1. The abdominal team entered the abdominal cavity and mobilized the sigmoid colon and rectum according to the principle of total mesorectal excision (TME). The vessels were ligated at a high position, and the rectum was dissected downward along the presacral space to the level of the levator ani muscle (pelvic floor), fully exposing the distal rectum and the levator ani muscle.
  2. The transanal team made a full-thickness circumferential incision in the rectal mucosa slightly above the dentate line (approximately ≥1 cm), entering the intersphincteric groove. A sharp circumferential dissection was performed along this groove to "pull" the rectum (along with its internal sphincter) out from within the external anal sphincter. During this dissection, care was taken to avoid damaging the external sphincter complex and its innervation.
  3. When the perineal dissection plane reached the level of

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Postoperative anal function as assessed by Wexner Score
Tidsram: At 3 and 6 months postoperatively

Scale Title: Wexner Fecal Incontinence Score. The minimum values:0. The maximum values:20. Higher scores mean a worse outcome.

At 3 and 6 months postoperatively
Postoperative quality of life as assessed by EORTC QLQ-C30
Tidsram: At 1 year postoperatively

Scale Title: European Organization for Research and Treatment of cancer Quality of Life Questionnaire. The minimum values:0. The maximum values:100. Higher scores mean a worse outcome.

At 1 year postoperatively
3-year local recurrence rate as assessed by abdominal contrast-enhanced MRI
Tidsram: 3 years postoperatively

Participants have an MRI every 3 months postoperatively

3 years postoperatively

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Circumferential resection margin negative rate
Tidsram: Immediately after the pathology results come out
Immediately after the pathology results come out
intraoperative blood loss
Tidsram: Immediately after the surgery
Immediately after the surgery
Postoperative-related complication incidence
Tidsram: From the end of surgery to 3 months postoperatively

Complications include postoperative bleeding, abdominal cavity infection, thoracic cavity infection, urinary tract infection, etc.

From the end of surgery to 3 months postoperatively
Postoperative hospital stay duration
Tidsram: From the end of surgery to discharge
From the end of surgery to discharge

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

8 februari 2026

Primärt slutförande (Beräknad)

1 juni 2027

Avslutad studie (Beräknad)

1 juni 2030

Studieregistreringsdatum

Först inskickad

8 maj 2026

Först inskickad som uppfyllde QC-kriterierna

29 september 2026

Första postat (Faktisk)

30 september 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

30 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

29 september 2026

Senast verifierad

1 maj 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • KY2025-246

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera